Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology

BACKGROUND: Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. This is an aggressive malignancy with a poor prognosis despite the high rates of response to chemotherapy. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Rais, Ghizlane, Raissouni, Soundouss, Aitelhaj, Meryem, Rais, Fadoi, Naciri, Sara, Khoyaali, Siham, Abahssain, Halima, Bensouda, Youssef, Khannoussi, Basma, Mrabti, Hind, Errihani, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492031/
https://www.ncbi.nlm.nih.gov/pubmed/23039971
http://dx.doi.org/10.1186/1472-6874-12-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492031/
https://www.ncbi.nlm.nih.gov/pubmed/23039971
http://dx.doi.org/10.1186/1472-6874-12-35

Ejemplares similares